217 related articles for article (PubMed ID: 19015642)
1. Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH.
Mahmoud M; Borthwick GM; Hislop AA; Arthur HM
Lab Invest; 2009 Jan; 89(1):15-25. PubMed ID: 19015642
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of arteriovenous malformations in the absence of endoglin.
Mahmoud M; Allinson KR; Zhai Z; Oakenfull R; Ghandi P; Adams RH; Fruttiger M; Arthur HM
Circ Res; 2010 Apr; 106(8):1425-33. PubMed ID: 20224041
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
Karlsson T; Cherif H
Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
[TBL] [Abstract][Full Text] [Related]
4. Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.
Garrido-Martin EM; Nguyen HL; Cunningham TA; Choe SW; Jiang Z; Arthur HM; Lee YJ; Oh SP
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2232-6. PubMed ID: 25082229
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis in hereditary haemorrhagic telangiectasia in Germany reveals 11 novel ENG and 12 novel ACVRL1/ALK1 mutations.
Wehner LE; Folz BJ; Argyriou L; Twelkemeyer S; Teske U; Geisthoff UW; Werner JA; Engel W; Nayernia K
Clin Genet; 2006 Mar; 69(3):239-45. PubMed ID: 16542389
[TBL] [Abstract][Full Text] [Related]
6. Arterial endoglin does not protect against arteriovenous malformations.
Singh E; Redgrave RE; Phillips HM; Arthur HM
Angiogenesis; 2020 Nov; 23(4):559-566. PubMed ID: 32506200
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
8. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension.
Gore B; Izikki M; Mercier O; Dewachter L; Fadel E; Humbert M; Dartevelle P; Simonneau G; Naeije R; Lebrin F; Eddahibi S
PLoS One; 2014; 9(6):e100310. PubMed ID: 24956016
[TBL] [Abstract][Full Text] [Related]
9. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment.
Ardelean DS; Jerkic M; Yin M; Peter M; Ngan B; Kerbel RS; Foster FS; Letarte M
Angiogenesis; 2014 Jan; 17(1):129-46. PubMed ID: 24061911
[TBL] [Abstract][Full Text] [Related]
10. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
[TBL] [Abstract][Full Text] [Related]
11. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
[TBL] [Abstract][Full Text] [Related]
12. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology.
Bofarid S; Hosman AE; Mager JJ; Snijder RJ; Post MC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801690
[TBL] [Abstract][Full Text] [Related]
14. Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2.
Du J; Zhu Y; Zhang YL; Li S; Huang J; Luo XH; Liu L
J Thromb Thrombolysis; 2015 Nov; 40(4):515-9. PubMed ID: 26245826
[TBL] [Abstract][Full Text] [Related]
15. Neuropilin-1 deficiency in vascular smooth muscle cells is associated with hereditary hemorrhagic telangiectasia arteriovenous malformations.
Kilari S; Wang Y; Singh A; Graham RP; Iyer V; Thompson SM; Torbenson MS; Mukhopadhyay D; Misra S
JCI Insight; 2022 May; 7(9):. PubMed ID: 35380991
[TBL] [Abstract][Full Text] [Related]
16. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
Seki T; Yun J; Oh SP
Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
[TBL] [Abstract][Full Text] [Related]
17. Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.
Lee ST; Kim JA; Jang SY; Kim DK; Do YS; Suh GY; Kim JW; Ki CS
J Korean Med Sci; 2009 Feb; 24(1):69-76. PubMed ID: 19270816
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia.
Kim MJ; Kim ST; Lee HD; Lee KY; Seo J; Lee JB; Lee YJ; Oh SP
BMC Med Genet; 2011 Oct; 12():130. PubMed ID: 21967607
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.
Latif MA; Sobreira NLD; Guthrie KS; Motaghi M; Robinson GM; Shafaat O; Gong AJ; Weiss CR
Am J Med Genet A; 2021 Jul; 185(7):1981-1990. PubMed ID: 33768677
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pulmonary arteriovenous malformations in ACVRL1 versus ENG mutation carriers in hereditary hemorrhagic telangiectasia.
Mu W; Cordner ZA; Yuqi Wang K; Reed K; Robinson G; Mitchell S; Lin D
Genet Med; 2018 Jun; 20(6):639-644. PubMed ID: 29048420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]